The drug is used to treat Diabetes 2 and will come in 3 mg sizes. BD
The Food and Drug Administration approved Impax Laboratories Inc.’s generic copies of a diabetes drug. Hayward-based Impax (NASDAQ: IPXL) plans to start selling the tablets, copies of Bayer’s Precose, in the fourth quarter of this year. They’ll be marketed in 25 mg, 50 mg and 100 mg sizes.